Hematologist
CION Cancer Clinics
Higher-risk MDS: azacitidine and beyond | CION Cancer Clinics
Azacitidine is the most common first treatment for higher-risk MDS when a transplant is not the immediate plan. It is usually given as injections under the skin for about seven days, repeated roughly every four weeks. It works slowly, so response is judged after several cycles. This page explains a cycle, the side effects, the other options and what it cannot promise. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
The short answer
How does azacitidine treat higher-risk MDS?
Azacitidine is the most common first treatment for higher-risk MDS in people who are not going straight to a transplant. It is usually given as injections under the skin for about seven days, repeated roughly every four weeks, and it can take several months to show whether it is working.
What it does
Azacitidine belongs to a group of medicines called hypomethylating agents. In MDS, some genes that help blood cells mature are switched off. Azacitidine helps switch them back on, so the marrow can make more normal cells. It also slows the faulty cells.
What it aims for
The goal is to improve blood counts, reduce transfusions, slow the change towards acute leukaemia and help people live longer with better quality of life. It does not remove MDS from the marrow for good. For that, a stem cell transplant is the only route, and it suits only some people.
Who it may not suit
It is usually not the first choice for lower-risk MDS, where gentler options come first. People with severe liver disease, or who are too unwell to attend regular visits, may need a different plan. For a young, fit person with a suitable donor, it may be used as a bridge to transplant rather than on its own.
One cycle, start to finish
What happens during a cycle of azacitidine?
Blood tests first
Counts, kidney and liver tests are checked before each cycle. If counts are very low, your team may delay or adjust the cycle.
The injection days
You come in daily for a short visit, usually for about seven days. The injection goes under the skin of the tummy, thigh or upper arm.
The rest weeks
The rest of the cycle is a break. Counts often dip during this time, so this is when infections and bleeding are most likely.
Checking the response
After several cycles your haematologist reviews counts and transfusion needs, and sometimes repeats the marrow test, to judge whether it is helping.
Not sure whether this applies to you?
Ask an oncologistBeyond azacitidine
What other options exist for higher-risk MDS?
Azacitidine is one part of a wider picture. Which option comes first depends on age, fitness, gene results and your wishes.
Stem cell transplant
The only treatment that can replace the faulty marrow. It carries serious risks, so it is offered to fitter people with a matched donor. CION does not perform transplants but coordinates referral to qualified centres.
Questions to ask
- Am I fit enough to be assessed?
- Should my siblings be tested as donors?
Decitabine
A closely related medicine that works in a similar way. It is given into a vein or, in some forms, as a tablet. It may be chosen when azacitidine is not suitable or not available.
Combinations and clinical trials
Azacitidine combined with newer medicines, such as venetoclax, is being studied. Evidence in MDS is still growing, so these are often offered within trials. Ask whether one is open to you.
Supportive care alone
Transfusions, infection treatment and symptom relief without disease-directed medicine. For some people who are frail, this is the kindest and most sensible choice.
!
One thing that cannot wait
A fever, shivering or feeling suddenly very unwell during azacitidine treatment can mean a serious infection while white cells are low. Go to the nearest emergency department the same day, or call 108, and tell them you are on azacitidine for MDS. Bleeding that will not stop needs the same urgency. Do not take paracetamol first and wait to see.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often get wrong about azacitidine?
"Two cycles and the counts are no better, so it has failed."
Azacitidine works slowly. Counts can even fall at first before they improve. Haematologists usually wait for several cycles before judging it. Stopping early can mean missing a response that was on its way.
"It is harsh chemotherapy, so he will lose all his hair."
Hair loss is uncommon with azacitidine. The more frequent effects are low counts, feeling sick, constipation, tiredness and redness where the injection went in. Most people have it as a day visit.
"Once the counts are normal, the injections can stop."
Good counts usually mean the treatment is working, not that it is finished. Stopping can let the disease return. Decisions about pausing or stopping belong to your treating haematologist.
"She is too old for treatment."
Azacitidine is widely used in older adults because it is gentler than intensive chemotherapy. Fitness and personal wishes matter more than age alone.
Words you will hear
What do the treatment terms mean?
- Hypomethylating agent
- The group of medicines azacitidine and decitabine belong to. They help switch silenced genes back on.
- Cycle
- One round of injection days followed by rest weeks. Treatment is counted in cycles.
- Haematological improvement
- Better blood counts or fewer transfusions, even if the marrow still shows MDS.
- Complete remission
- Remission means the marrow and blood counts look close to normal on testing. It does not mean the MDS has gone for good.
- Bridge to transplant
- Treatment given to control the disease while a transplant is being arranged.
Being straight with you
What can this page not tell you?
This page cannot tell you whether azacitidine will work for you, how long it will keep working, or whether another option would suit you better. Response varies widely, and no test can predict it reliably beforehand.
Doses and schedules belong to your team
The dose depends on your body size, your counts and your kidney function. Your schedule may be changed between cycles. Never skip, delay or stop a cycle on your own, even if you feel better.
What to ask before you start
Ask what the aim of treatment is for you. Ask how many cycles will be given before the response is judged, and how it will be judged. Ask whether a transplant is possible, and whether family members should be tested as donors. Ask where the injections will be given and who to call if a fever starts at night. At CION the haematology team reviews the case and presents it at a tumour board before a plan is confirmed, and coordinates access to treatment given at other centres.
Nothing on this page claims that CION supplies any particular medicine. Availability is discussed at your appointment.Questions we are asked
Common questions about azacitidine for MDS
How long will treatment go on?
If azacitidine is helping and side effects are manageable, it is usually continued for as long as it keeps working. There is no fixed end date for most people. Your haematologist reviews the response regularly and discusses whether to continue, change or stop.
Can azacitidine be given at home?
In most places it is given at a hospital or day-care unit, because the medicine needs careful handling and a nurse checks you. Some centres give it closer to home. Ask your team what arrangements are possible for your family.
What are the common side effects?
Low blood counts are the most important, raising the chance of infection and bleeding. Feeling sick, constipation, tiredness, and redness or itching where the injection went in are common. Medicines can ease sickness. Tell your team about every new symptom rather than waiting for the next cycle.
Why did the counts drop after starting treatment?
Counts often fall in the first cycles, before any improvement shows. This is expected and does not mean the treatment has failed. It is why blood tests are frequent at the start, and why transfusions or infection treatment may be needed during this time.
Can azacitidine make MDS go away completely?
Some people reach remission, where the marrow looks close to normal. That is a good result, but MDS usually returns if treatment stops. Azacitidine controls the disease rather than removing it permanently. Only a stem cell transplant offers that possibility, and only for some people.
What happens if azacitidine stops working?
Your haematologist will repeat tests to see what has changed. Options may include a clinical trial, a different medicine, transplant assessment if you are fit, or supportive care focused on comfort. This is a hard conversation, and it is fine to bring family and ask for time.
Can I travel from my district for each cycle?
Many families travel from districts across Telangana and Andhra Pradesh. Because injection days run in a row, some stay nearby for that week. Ask whether blood tests between cycles can be done closer to home, and keep a written plan for fevers while away.
Is azacitidine covered by Aarogyasri or insurance?
It may be covered under Aarogyasri, CGHS, ECHS, EHS, PM-JAY or cashless insurance when part of an approved plan. Coverage and scheme rules change, so check the current terms. Call the helpline with your card details and the team will check your cover.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- Macmillan Cancer Support — Azacitidine
- American Cancer Society — Treating myelodysplastic syndromes
- National Cancer Institute — Myelodysplastic Syndromes Treatment (PDQ), Patient Version
- Leukemia & Lymphoma Society — Myelodysplastic syndromes
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Talk to us
Has azacitidine been suggested?
Tell us what has been found so far. The haematology team will go through the plan and the options with you. One helpline serves every CION centre.